UBS Group
TELA icon

UBS Group’s TELA Bio TELA Stock Holding History

UBS Group’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$657K Sell
1,059,524
-440,945
-29% -$383K ﹤0.01% 5871
2025
Q4 		$1.77M Buy
1,500,469
+1,283,667
+592% +$1.62M ﹤0.01% 5078
2025
Q3 		$323K Sell
216,802
-28,746
-12% -$50.6K ﹤0.01% 6384
2025
Q2 		$476K Sell
245,548
-85,135
-26% -$111K ﹤0.01% 6049
2025
Q1 		$403K Sell
330,683
-437,147
-57% -$1.07M ﹤0.01% 6023
2024
Q4 		$2.32M Buy
+767,830
New +$2.16M ﹤0.01% 4584
2024
Q3 		– Sell
-4,367
Closed -$20.5K – 10060
2024
Q2 		$20.5K Sell
4,367
-13,645
-76% -$71.9K ﹤0.01% 7287
2024
Q1 		$102K Sell
18,012
-670,910
-97% -$4.42M ﹤0.01% 6213
2023
Q4 		$4.56M Buy
688,922
+677,933
+6,169% +$3.92M ﹤0.01% 2882
2023
Q3 		$87.9K Buy
10,989
+1,789
+19% +$16.6K ﹤0.01% 5914
2023
Q2 		$93.2K Buy
9,200
+8,266
+885% +$84.5K ﹤0.01% 6068
2023
Q1 		$9.94K Sell
934
-2,477
-73% -$27.3K ﹤0.01% 7619
2022
Q4 		$39.2K Buy
3,411
+132
+4% +$1.18K ﹤0.01% 6991
2022
Q3 		$28K Buy
3,279
+1,194
+57% +$9.9K ﹤0.01% 6965
2022
Q2 		$15K Buy
2,085
+953
+84% +$7.91K ﹤0.01% 7316
2022
Q1 		$13K Sell
1,132
-11,717
-91% -$142K ﹤0.01% 8080
2021
Q4 		$164K Sell
12,849
-743
-5% -$9.41K ﹤0.01% 5863
2021
Q3 		$186K Buy
13,592
+236
+2% +$3.29K ﹤0.01% 5384
2021
Q2 		$215K Sell
13,356
-1,383
-9% -$19K ﹤0.01% 5292
2021
Q1 		$220K Buy
14,739
+317
+2% +$4.77K ﹤0.01% 5418
2020
Q4 		$217K Sell
14,422
-2,966
-17% -$48.1K ﹤0.01% 5194
2020
Q3 		$288K Sell
17,388
-854
-5% -$12K ﹤0.01% 4574
2020
Q2 		$236K Buy
18,242
+2,061
+13% +$27.1K ﹤0.01% 4681
2020
Q1 		$127K Hold
16,181
– – ﹤0.01% 5075
2019
Q4 		$210K Buy
+16,181
New +$198K ﹤0.01% 5573

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group's TELA Position: Q1 2026 in Review

UBS Group reduced its TELA Bio (TELA) stake by 29% in Q1 2026, selling an estimated $383K and leaving 1,059,524 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #5871.

UBS Group first reported a position in TELA in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.56M in Q4 2023. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • UBS Group held 1,059,524 shares of TELA Bio worth $657K as of Q1 2026.
  • UBS Group sold 440,945 TELA Bio shares in Q1 2026, an estimated $383K.
  • TELA Bio made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5871 holding.
  • UBS Group first reported a position in TELA Bio in Q4 2019 and has held it in 25 quarters since.
  • UBS Group's TELA Bio position peaked at $4.56M in Q4 2023.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.